Marshall Wace North America’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $11.7M | Buy |
231,977
+219,062
| +1,696% | +$11.1M | 0.05% | 320 |
|
|
2021
Q2 | $1.01M | Sell |
12,915
-263,011
| -95% | -$20.6M | ﹤0.01% | 973 |
|
|
2021
Q1 | $15.8M | Buy |
275,926
+225,720
| +450% | +$12.9M | 0.07% | 303 |
|
|
2020
Q4 | $4.21M | Sell |
50,206
-396,600
| -89% | -$33.2M | 0.02% | 576 |
|
|
2020
Q3 | $16M | Sell |
446,806
-394,075
| -47% | -$14.1M | 0.1% | 213 |
|
|
2020
Q2 | $20.3M | Sell |
840,881
-323,471
| -28% | -$7.82M | 0.13% | 172 |
|
|
2020
Q1 | $20.4M | Buy |
1,164,352
+766,441
| +193% | +$13.4M | 0.15% | 154 |
|
|
2019
Q4 | $6.93M | Buy |
+397,911
| New | +$6.93M | 0.03% | 342 |
|
|
2018
Q1 | – | Sell |
-45,333
| Closed | -$709K | – | 1490 |
|
|
2017
Q4 | $709K | Buy |
+45,333
| New | +$709K | ﹤0.01% | 1065 |
|